2Steven M.,Richard L..Antiendotoxin strategies for the prevention and treatment of septic shock[J].Drugs,1998,55(4):97
3Kobayashi S.,Kawata T.,Kimura A.,et al.Suppression of murine endotoxin response by E5531,a novel synthetic lipid A antagonist[J].Antimicrob Agents Chemother,1998,42(11):2824
4Solomon SB.,Cui X.,Gerstenberger E.,et al.Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection[J].J Infect Dis.,2006,193(5):634～644
5Triantafilou M.,Triantafilou K.,Fernandez N..Rough and smooth forms offluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influenced by endotoxin concentration[J].Eur J Biochem,2000,267 (8):2218 ～ 2226
6Kitchens R L.,Thompson P A.,Viriyakosol S.,et al.Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins[J].JClin Invest,2001,108 (4):485～493
10Morresey PR.,Mackay RJ..Endotoxin-neutralizing activity of polymyxin B in blood after Ⅳ administration in horses[J].AM J Vet Res.,2006,67(4):642 ～ 647
10Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/ toll-like receptor 4 signaling in chronic liver dis- eases. Hepatol Int 2010; 4:659-672 [PMID: 21286336 DOI: 10.1007/s12072-010-9219-x].
